Correlation Between Bio Path and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bio Path and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Altamira Therapeutics, you can compare the effects of market volatilities on Bio Path and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Altamira Therapeutics.
Diversification Opportunities for Bio Path and Altamira Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Bio and Altamira is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Bio Path i.e., Bio Path and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Bio Path and Altamira Therapeutics
Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Altamira Therapeutics. In addition to that, Bio Path is 1.07 times more volatile than Altamira Therapeutics. It trades about -0.2 of its total potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.16 per unit of volatility. If you would invest 48.00 in Altamira Therapeutics on August 31, 2024 and sell it today you would lose (8.00) from holding Altamira Therapeutics or give up 16.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bio Path Holdings vs. Altamira Therapeutics
Performance |
| Timeline |
| Bio Path Holdings |
| Altamira Therapeutics |
Bio Path and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bio Path and Altamira Therapeutics
The main advantage of trading using opposite Bio Path and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
| Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Correlations Find global opportunities by holding instruments from different markets |